MediWound (MDWD) Exchange Rate Effect (2013 - 2026)
MediWound (MDWD) posted Exchange Rate Effect of $109000.0 for Q2 2026, up 475.86% on a QoQ basis from -$29000.0 in Q1 2026, and up 5350.0% year-over-year from $2000.0 in Q2 2025.
Powered by 
Analysis
MediWound (MDWD) Exchange Rate Effect (2013 - 2026) Analysis & Trends
MediWound has reported Exchange Rate Effect for 14 years, with the latest figure at $109000.0 in Q2 2026.
- On a quarterly basis, Exchange Rate Effect rose 5350.0% year-over-year to $109000.0 in Q2 2026; TTM through Jun 2026 was $154000.0, a 275.61% increase from a year earlier, with the FY2025 full-year figure at $95000.0, up 213.1% from the prior year.
- Exchange Rate Effect was $109000.0 for Q2 2026 at MediWound, up from -$29000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $378000.0 in Q4 2023, with the low at -$337000.0 in Q1 2023.
- Average Exchange Rate Effect over 5 years is -$34333.3, with a median of -$6500.0 recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Exchange Rate Effect sank 280.0% in 2023, then soared 5350.0% in 2026.
- Over 5 years, Exchange Rate Effect stood at -$44000.0 in 2022, then jumped by 959.09% to $378000.0 in 2023, then slumped by 99.47% to $2000.0 in 2024, then jumped by 2950.0% to $61000.0 in 2025, then surged by 78.69% to $109000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $109000.0 (Q2 2026), -$29000.0 (Q1 2026), and $61000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 109,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 109,000.00 |
| Mar 31, 2026 | -29,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -89,000.00 |
| Dec 31, 2023 | 378,000.00 |
| Sep 30, 2023 | -81,000.00 |
| Jun 30, 2023 | -120,000.00 |
| Mar 31, 2023 | -337,000.00 |
| Dec 31, 2022 | -44,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | -303,000.00 |
| Mar 31, 2022 | -247,000.00 |
| Dec 31, 2021 | -109,000.00 |
| Sep 30, 2021 | -7,000.00 |